PT82071A - Process for preparing homocysteine thiolactone derivatives - Google Patents

Process for preparing homocysteine thiolactone derivatives

Info

Publication number
PT82071A
PT82071A PT82071A PT8207186A PT82071A PT 82071 A PT82071 A PT 82071A PT 82071 A PT82071 A PT 82071A PT 8207186 A PT8207186 A PT 8207186A PT 82071 A PT82071 A PT 82071A
Authority
PT
Portugal
Prior art keywords
preparing
homocysteine thiolactone
thiolactone derivatives
compounds
derivatives
Prior art date
Application number
PT82071A
Other languages
English (en)
Other versions
PT82071B (pt
Inventor
Paolo Chiesi
Vittorino Servadio
Original Assignee
Chiesi Farma Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chiesi Farma Spa filed Critical Chiesi Farma Spa
Publication of PT82071A publication Critical patent/PT82071A/pt
Publication of PT82071B publication Critical patent/PT82071B/pt

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/12Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/10Expectorants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D333/00Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/26Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D333/30Hetero atoms other than halogen
    • C07D333/36Nitrogen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D493/00Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
    • C07D493/02Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
    • C07D493/08Bridged systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pulmonology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Heterocyclic Compounds Containing Sulfur Atoms (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
PT82071A 1985-02-22 1986-02-21 Processo para a preparacao de derivados de homocisteina tiolactona PT82071B (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT8519621A IT1215238B (it) 1985-02-22 1985-02-22 Derivati di omocisteina tiolattone,loro procedimento di preparazione e formulazioni farmaceutiche

Publications (2)

Publication Number Publication Date
PT82071A true PT82071A (en) 1986-03-01
PT82071B PT82071B (pt) 1987-12-30

Family

ID=11159747

Family Applications (1)

Application Number Title Priority Date Filing Date
PT82071A PT82071B (pt) 1985-02-22 1986-02-21 Processo para a preparacao de derivados de homocisteina tiolactona

Country Status (8)

Country Link
US (1) US4690944A (pt)
EP (1) EP0192191B1 (pt)
JP (1) JPS61227579A (pt)
AT (1) ATE42287T1 (pt)
DE (1) DE3662887D1 (pt)
ES (1) ES8708134A1 (pt)
IT (1) IT1215238B (pt)
PT (1) PT82071B (pt)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1254530B (it) * 1992-03-18 1995-09-25 Derivati mercapto acetamidici
US5237057A (en) * 1992-04-06 1993-08-17 Biosite Diagnostics, Inc. Tetrahydrocannabinol derivatives and protein and polypeptide tetrahydrocannabinol derivative conjugates and labels
US5274122A (en) * 1992-10-15 1993-12-28 Merck & Co., Inc. Acidic derivatives of homocysteine thiolactone
ES2061397B1 (es) * 1993-03-02 1996-02-16 Prodesfarma Sa Procedimiento de obtencion de n-acetil homocisteina tiolactona a partir de nn-acetil homocistina por metodos electroquimicos.
ES2061398B1 (es) * 1993-03-02 1996-02-16 Prodesfarma Sa Procedimiento de obtencion de n-acetil homocisteina tiolactona a partir del dl-homocistina por metodos electroquimicos.

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2129877B1 (pt) * 1971-03-18 1974-08-02 Fuveau Sa
FR2265355B1 (pt) * 1974-03-28 1977-11-04 Blum Jean
IT1068217B (it) * 1976-10-14 1985-03-21 Sigma Tau Ind Farmaceuti Omocisteina tiolattone 6 cloro nicotinamide
FR2502153A1 (fr) * 1981-03-19 1982-09-24 Rech Pharmaceutiq Medicale Acides (2-oxo-3-tetrahydrothienylcarbamoyl)-alkylthio) acetiques, leurs sels et leurs esters, leur procede de preparation et les compositions pharmaceutiques en contenant

Also Published As

Publication number Publication date
ATE42287T1 (de) 1989-05-15
EP0192191B1 (en) 1989-04-19
ES8708134A1 (es) 1987-09-16
DE3662887D1 (en) 1989-05-24
JPH0322878B2 (pt) 1991-03-27
EP0192191A1 (en) 1986-08-27
ES552281A0 (es) 1987-09-16
IT1215238B (it) 1990-01-31
IT8519621A0 (it) 1985-02-22
US4690944A (en) 1987-09-01
PT82071B (pt) 1987-12-30
JPS61227579A (ja) 1986-10-09

Similar Documents

Publication Publication Date Title
DK175689D0 (da) 4-acylcephemsulfon- eller 3-acylpenamsulfonforbindelser, fremgangsmaade til fremstilling deraf samt farmaceutiske praeparater indeholdende samme
HUT41713A (en) Process for production of //arol-cyclobutyl/ alkyl/-amins and medical preparatives containing thereof
DE3363248D1 (en) Use of pyridine compounds for the manufacture of medicaments with an antihypoxemia and ischemia-protective activity
EP0189960A3 (en) Novel insecticidal 1,3-thiazole derivatives
ES8604543A1 (es) Procedimiento para la obtencion de derivados piperazinicos
PT82071A (en) Process for preparing homocysteine thiolactone derivatives
UA8017A1 (uk) Спосіб отримання похідних хінолінкарбонової кислоти
ES8604960A1 (es) Procedimiento para preparar derivados de 1,6-naftiridina
ES8405768A1 (es) Un procedimiento para preparar en todas sus formas estereoisomeras, o en forma de mezclas de estereoisomeros, derivados de acido ciclopropanocarboxilico
EP0222371A3 (en) Thiazolidine derivatives, process for their preparation and pharmaceutical compositions
ES2019871B3 (es) 1,2,3,4,4a,9b-hexahidro-4a-aminoalquildibenzofuranos, un proceso para su preparacion y su uso como medicamentos.
GB1284379A (en) Substituted 4,5-diphenyloxazoles
FR2471369B1 (pt)
AU6679786A (en) 5-aminoalkyl-beta-carboline derivatives, their production and their use as drugs
GR3005201T3 (pt)
ES8401952A1 (es) Un procedimiento para preparar nuevos derivados de 1,4-benzotiazina.
DK141187A (da) 1-(3-(2-dialkylaminoethoxy)-2-thienyl)-3-phenyl-1-propanoner og syreadditionssalte deraf, fremgangsmaade af saadanne forbindelser samt farmaceutiske praeparater indeholdende disse
JPS53127490A (en) Novel nitrogen-containing heterocyclic compound
ES2025140B3 (es) Herbicidas heterociclicos.
FR2315507A1 (fr) Imidazo /1,2-b/ pyridazines substituees, procede de preparation et compositions pesticides les renfermant
JPS5439089A (en) Five-membered heterocycles having nitro group

Legal Events

Date Code Title Description
MM3A Annulment or lapse

Free format text: LAPSE DUE TO NON-PAYMENT OF FEES

Effective date: 19931231